Multi Medika (Indonesia) Market Value
| MMIX Stock | 82.00 1.00 1.20% |
| Symbol | Multi |
Multi Medika 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Multi Medika's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Multi Medika.
| 02/29/2024 |
| 11/25/2024 |
If you would invest 0.00 in Multi Medika on February 29, 2024 and sell it all today you would earn a total of 0.00 from holding Multi Medika Internasional or generate 0.0% return on investment in Multi Medika over 270 days. Multi Medika is related to or competes with Bakrie Brothers, Langgeng Makmur, Petrosea Tbk, Graha Layar, Bank Pan, Pudjiadi Sons, and Sejahteraraya Anugrahjaya. More
Multi Medika Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Multi Medika's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Multi Medika Internasional upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.47 | |||
| Information Ratio | 0.0897 | |||
| Maximum Drawdown | 49.93 | |||
| Value At Risk | (5.13) | |||
| Potential Upside | 10.67 |
Multi Medika Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Multi Medika's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Multi Medika's standard deviation. In reality, there are many statistical measures that can use Multi Medika historical prices to predict the future Multi Medika's volatility.| Risk Adjusted Performance | 0.093 | |||
| Jensen Alpha | 0.859 | |||
| Total Risk Alpha | (0.32) | |||
| Sortino Ratio | 0.1314 | |||
| Treynor Ratio | (0.57) |
Multi Medika Interna Backtested Returns
Multi Medika appears to be not too volatile, given 3 months investment horizon. Multi Medika Interna has Sharpe Ratio of 0.12, which conveys that the firm had a 0.12% return per unit of risk over the last 3 months. By analyzing Multi Medika's technical indicators, you can evaluate if the expected return of 0.79% is justified by implied risk. Please exercise Multi Medika's Mean Deviation of 3.86, downside deviation of 4.47, and Risk Adjusted Performance of 0.093 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Multi Medika holds a performance score of 9. The company secures a Beta (Market Risk) of -1.25, which conveys a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Multi Medika are expected to decrease by larger amounts. On the other hand, during market turmoil, Multi Medika is expected to outperform it. Please check Multi Medika's total risk alpha, treynor ratio, and the relationship between the jensen alpha and sortino ratio , to make a quick decision on whether Multi Medika's current price movements will revert.
Auto-correlation | -0.49 |
Modest reverse predictability
Multi Medika Internasional has modest reverse predictability. Overlapping area represents the amount of predictability between Multi Medika time series from 29th of February 2024 to 13th of July 2024 and 13th of July 2024 to 25th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Multi Medika Interna price movement. The serial correlation of -0.49 indicates that about 49.0% of current Multi Medika price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.49 | |
| Spearman Rank Test | -0.23 | |
| Residual Average | 0.0 | |
| Price Variance | 70.08 |
Multi Medika Interna lagged returns against current returns
Autocorrelation, which is Multi Medika stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Multi Medika's stock expected returns. We can calculate the autocorrelation of Multi Medika returns to help us make a trade decision. For example, suppose you find that Multi Medika has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Multi Medika regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Multi Medika stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Multi Medika stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Multi Medika stock over time.
Current vs Lagged Prices |
| Timeline |
Multi Medika Lagged Returns
When evaluating Multi Medika's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Multi Medika stock have on its future price. Multi Medika autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Multi Medika autocorrelation shows the relationship between Multi Medika stock current value and its past values and can show if there is a momentum factor associated with investing in Multi Medika Internasional.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Multi Stock
Multi Medika financial ratios help investors to determine whether Multi Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Multi with respect to the benefits of owning Multi Medika security.